Candid Health — $120M Series D for AI Revenue Cycle Management Platform
ENTITYCandid Health has raised $120 million in a Series D funding round led by Sixth Street Growth, with participation from Oak HC/FT, 8VC, and Y Combinator. The company's AI-powered revenue cycle management (RCM) platform automates claims processing, coding, and payer communication workflows for healthcare providers. The funding round is among the larger RCM-specific AI raises in 2026, reflecting sustained investor conviction in AI's ability to generate measurable ROI in administrative healthcare functions. RCM represents a particularly attractive AI application because the value is directly quantifiable (denial rates, days in AR, clean claim rates), the workflows are highly repetitive and rule-based, and the market is large — US healthcare administrative costs exceed $800 billion annually. Candid's investor syndicate is notable: Y Combinator participation signals early-stage validation, while Sixth Street Growth's lead indicates the company has reached scale sufficient for growth-stage institutional capital. Oak HC/FT and 8VC bring healthcare-specific expertise that can support regulatory navigation and health system enterprise sales. The raise positions Candid alongside other well-funded AI RCM players and intensifies competition in a market that includes both AI-native startups and legacy RCM vendors adding AI capabilities to existing platforms. ---
Subscribe to read full wiki analysis
Full wiki content — including source provenance, contradiction tracking, related pages, and analyst notes — is available to Subscriber members.
View Plans & SubscribeNew users get a 7-day trial — no credit card required.